Market Share of Psoriatic Arthritis Therapeutics Industry
The psoriatic arthritis therapeutics market is characterized by moderate fragmentation, with only a few key players dominating the industry. The majority of these key players involved in the research and development of psoriatic arthritis therapy drugs are located in developed countries. Established market leaders with greater funds for research and development and better distribution systems have already established a strong foothold in the market. The presence of major players such as AbbVie Inc., Johnson & Johnson, Pfizer Inc., Sanofi S.A., and Celgene Corporation (Bristol-Myers Squibb) is further intensifying the overall competitive rivalry in the market.
Psoriatic Arthritis Therapeutics Market Leaders
AbbVie Inc
Johnson & Johnson
Pfizer Inc.
Sanofi S.A.
Celgene Corporation (Bristol-Myers Squibb)
*Disclaimer: Major Players sorted in no particular order